Please disable your adblock and script blockers to view this page

Bristol-Myers to buy Celgene in a $74 billion deal; Celgene shares surge


InBristol-Myers Squibb
Celgene
Juno Therapeutics
PlayingShare
CNBC
CNBC LLC
All Rights Reserved
Division
NBCUniversalData
Global Business and Financial News
Market Data and Analysis


Celgene
Giovanni Caforio
Watch Next

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags